BIVIGAM

anti-D immunoglobulin? (Note: BIVIGAM is a human intravenous immunoglobulin product) · ADMA Biologics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIVIGAM, covering 2023-02-01 to 2023-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16 [Phase 4]

See pricing